Zymeworks, Inc. (ZYME)
27.74
+0.76
(+2.82%)
USD |
NASDAQ |
Apr 15, 16:00
27.74
0.00 (0.00%)
After-Hours: 18:29
Zymeworks Research and Development Expense (Annual) : 137.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Royalty Pharma Plc | 452.00M |
| Krystal Biotech, Inc. | 52.32M |
| Scholar Rock Holding Corp. | 206.78M |
| Xeris Biopharma Holdings, Inc. | 31.16M |
| Stoke Therapeutics, Inc. | 136.15M |